Global Endowment Management LP Cuts Stock Position in Oscar Health, Inc. (NYSE:OSCR)

Global Endowment Management LP cut its holdings in shares of Oscar Health, Inc. (NYSE:OSCR) by 49.5% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 19,429 shares of the company’s stock after selling 19,017 shares during the period. Global Endowment Management LP’s holdings in Oscar Health were worth $255,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Larson Financial Group LLC increased its stake in shares of Oscar Health by 83,733.3% during the first quarter. Larson Financial Group LLC now owns 2,515 shares of the company’s stock worth $33,000 after buying an additional 2,512 shares during the period. CWM LLC increased its stake in shares of Oscar Health by 50.7% during the first quarter. CWM LLC now owns 3,204 shares of the company’s stock worth $42,000 after buying an additional 1,078 shares during the period. Caitong International Asset Management Co. Ltd increased its stake in shares of Oscar Health by 484.6% during the first quarter. Caitong International Asset Management Co. Ltd now owns 3,443 shares of the company’s stock worth $45,000 after buying an additional 2,854 shares during the period. Princeton Global Asset Management LLC purchased a new stake in shares of Oscar Health during the first quarter worth approximately $59,000. Finally, GAMMA Investing LLC increased its stake in shares of Oscar Health by 2,156.4% during the first quarter. GAMMA Investing LLC now owns 6,476 shares of the company’s stock worth $85,000 after buying an additional 6,189 shares during the period. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

OSCR has been the topic of a number of recent research reports. Barclays cut their target price on shares of Oscar Health from $17.00 to $11.00 and set an “underweight” rating on the stock in a research note on Wednesday, July 23rd. Piper Sandler restated a “neutral” rating and set a $13.00 target price (down from $14.00) on shares of Oscar Health in a research note on Thursday. Raymond James Financial lowered shares of Oscar Health from an “outperform” rating to a “market perform” rating in a research note on Tuesday, June 24th. Baird R W lowered shares of Oscar Health from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 25th. Finally, Wells Fargo & Company downgraded Oscar Health from an “equal weight” rating to an “underweight” rating and lowered their price target for the company from $16.00 to $10.00 in a report on Friday, July 11th. Six research analysts have rated the stock with a sell rating and four have issued a hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Reduce” and a consensus price target of $12.07.

Oscar Health Stock Performance

Shares of OSCR opened at $15.63 on Friday. The stock has a 50 day moving average price of $15.94 and a 200 day moving average price of $14.82. The company has a quick ratio of 0.86, a current ratio of 0.86 and a debt-to-equity ratio of 0.26. The company has a market capitalization of $3.98 billion, a price-to-earnings ratio of -19.30 and a beta of 1.86. Oscar Health, Inc. has a 52-week low of $11.20 and a 52-week high of $23.79.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.90) by $0.01. The firm had revenue of $2.86 billion during the quarter, compared to the consensus estimate of $2.88 billion. Oscar Health had a negative return on equity of 13.78% and a negative net margin of 1.50%. The firm’s quarterly revenue was up 29.0% compared to the same quarter last year. During the same period in the prior year, the company posted $0.20 earnings per share. Research analysts predict that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.